Jazz Pharmaceuticals Provides Update on Cannabidiol Oral Solution Phase 3 Trial in Japan in Treatment-Resistant Epilepsies
Jazz Pharmaceuticals(JAZZ) Prnewswire·2024-08-23 04:05Jazz Pharmaceuticals(JAZZ) Prnewswire·2024-08-23 04:05
R1Jazz Pharmaceuticals(JAZZ) Prnewswire·2024-08-23 04:05